Renal Pelvis and Ureter Carcinoma — Trials

Renal Pelvis and Ureter Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

105 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 48
Recruiting: 27
Ph III recruiting: 6
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07720921	Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )(LUXUS0701)	not yet recruiting	Phase 2	20	Peking University First HospitalOTHER	1	Jul 22, 2026	clinicaltrials
NCT07591805	HERO-UTUC: Intravesical RC48 After RNU for HER2+ UTUC(HERO-UTUC)	not yet recruiting	Phase 2	49	RenJi HospitalOTHER	1	May 18, 2026